BRUNO, PIETRO ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 117
AS - Asia 78
EU - Europa 69
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 4
Totale 289
Nazione #
US - Stati Uniti d'America 114
IT - Italia 41
SG - Singapore 33
CN - Cina 16
VN - Vietnam 16
BR - Brasile 12
GB - Regno Unito 7
IN - India 7
DE - Germania 6
NL - Olanda 6
EE - Estonia 4
BD - Bangladesh 2
CZ - Repubblica Ceca 2
MA - Marocco 2
PK - Pakistan 2
AR - Argentina 1
CA - Canada 1
CR - Costa Rica 1
EC - Ecuador 1
EG - Egitto 1
FR - Francia 1
JP - Giappone 1
MX - Messico 1
NG - Nigeria 1
PL - Polonia 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 282
Città #
San Jose 29
Ashburn 16
Singapore 12
Dallas 7
Phoenix 7
Council Bluffs 6
Munich 6
Santa Clara 6
Beijing 5
Los Angeles 5
Milan 5
Bengaluru 4
Hanoi 4
Hefei 4
Ho Chi Minh City 4
Misterbianco 4
Taranto 4
Boardman 3
Cittanova 3
London 3
Amantea 2
Aversa 2
Biên Hòa 2
City of Westminster 2
Morciano di Leuca 2
New York 2
Olomouc 2
Palo del Colle 2
Shenzhen 2
Turin 2
West Jordan 2
Alexandria 1
Amritsar 1
Amsterdam 1
Banning 1
Bari 1
Bitonto 1
Boston 1
Bắc Giang 1
Canguçu 1
Casablanca 1
Casca 1
Chennai 1
Chester 1
Chicago 1
Chihuahua City 1
Cianorte 1
Columbia 1
Céu Azul 1
Da Nang 1
Dourados 1
Florence 1
Guarulhos 1
Guayaquil 1
Haiphong 1
Hellevoetsluis 1
Hounslow 1
Houston 1
Hải Dương 1
Jardín América 1
Lahore 1
Las Vegas 1
Lucknow 1
Multan 1
Newcastle upon Tyne 1
Ninh Bình 1
Noyon 1
Palermo 1
Riacho das Almas 1
Rio de Janeiro 1
Saint Paul 1
Salvador 1
San Francisco 1
San José 1
Sapucaia do Sul 1
Saratov 1
São Sebastião do Caí 1
Tangier 1
Texas City 1
Thái Bình 1
Tokyo 1
Urânia 1
Warsaw 1
West Vancouver 1
Yonkers 1
Totale 213
Nome #
Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients: Correlations with DMTs and clinical variables 75
Fatigue in natalizumab-treated Multiple Sclerosis patients: How much is wearing-off to blame? 72
Neurological manifestations in patients and disease carriers in an Italian family with osteosclerosis 58
Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic 53
Nabiximols improves sleep architecture in multiple sclerosis: A prospective polysomnographic study 18
B-cell–driven relapse and anti-CD20 rescue therapy after Alemtuzumab in RRMS: case report and literature review 13
Totale 289
Categoria #
all - tutte 1.841
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.841


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20234 0 0 0 0 0 0 4 0 0 0 0 0
2023/202434 1 6 1 2 2 3 13 2 0 2 0 2
2024/202543 5 0 0 0 5 3 0 1 8 4 7 10
2025/2026159 15 20 13 23 15 8 20 7 13 13 11 1
2026/202749 0 10 28 11 0 0 0 0 0 0 0 0
Totale 289